Sign inJoin waitlistJoin the waitlist

SB

Sanjeeve Balasubramaniam

Hematology & Oncology

Credentials: · ·

History

Hematology and Medical Oncology
Clinical Center at the National Institutes of Health
2006–2011
MedStar Georgetown University Hospital
2003–2006
General Surgery
SSM Health/Saint Louis University School of Medicine
1998–2002
State University of New York Upstate Medical University
1994–1998

Research

FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
The Oncologist · 2021 · 151 citations
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis
The Lancet Oncology · 2018 · 143 citations
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Ovarian Cancer
Clinical Cancer Research · 2017 · First of 26 authors · Corresponding · 136 citations

Susan Bates
10 papers
Tito Fojo
8 papers
RP
Richard Pazdur
7 papers
RP
Richard Piekarz
5 papers
William Figg
5 papers
GK
Geoffrey Kim
4 papers
Aradhana Venkatesan
3 papers
Ciara O'Sullivan
3 papers · 2 as a fellow
MT
Marc Theoret
3 papers · 1 as a resident
GG
Giuseppe Giaccone
2 papers
JB
Julia Beaver
2 papers
MC
Meredith Chuk
2 papers